Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

NCT05226871 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Head and Neck Cancer

Interventions

DRUG: Palbociclib
DRUG: Cetuximab
DRUG: Fulvestrant
DRUG: Letrozole

Sponsor

Pfizer